drugset / Trial / NCT00990756
A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to investigate safety and toleration of multiple inhaled doses as well as the time course of PF-03526299 concentration in the blood following dosing by dry powder inhaler.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03526299 | Unknown | 1.396 mg | Inhaled |
| Subject | PF-03526299 | Unknown | 4 mg | Inhaled |
Indications
No indication recorded.